115 related articles for article (PubMed ID: 9350598)
21. Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study).
Pratt CM; McMahon RP; Goldstein S; Pepine CJ; Andrews TC; Dyrda I; Frishman WH; Geller NL; Hill JA; Morgan NA; Stone PH; Knatterud GL; Sopko G; Conti CR
Am J Cardiol; 1996 Jun; 77(15):1302-9. PubMed ID: 8677870
[TBL] [Abstract][Full Text] [Related]
22. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
Deanfield JE; Detry JM; Sellier P; Lichtlen PR; Thaulow E; Bultas J; Brennan C; Young ST; Beckerman B;
J Am Coll Cardiol; 2002 Sep; 40(5):917-25. PubMed ID: 12225716
[TBL] [Abstract][Full Text] [Related]
23. Amlodipine versus diltiazem CR in the reduction of the total ischemic burden: the Circadian Anti-Ischemia Program in Europe (CAPE) II trial--clinical rationale and methodology.
Deanfield JE
Cardiovasc Drugs Ther; 1998 Oct; 12 Suppl 3():239-42. PubMed ID: 9800053
[TBL] [Abstract][Full Text] [Related]
24. The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects.
Kovarik JM; Lu M; Riviere GJ; Barbet I; Maton S; Goldwater DR; Schmouder RL
Eur J Clin Pharmacol; 2008 May; 64(5):457-63. PubMed ID: 18196225
[TBL] [Abstract][Full Text] [Related]
25. Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia.
Steffensen R; Grande P; Pedersen F; Haunsø S
Int J Cardiol; 1993 Jul; 40(2):143-53. PubMed ID: 8349377
[TBL] [Abstract][Full Text] [Related]
26. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
Myburgh DP; Gordon NF
Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
[TBL] [Abstract][Full Text] [Related]
27. Role of diltiazem in the treatment of silent myocardial ischemia.
Waters D; Juneau M; Baird M; Klinke P; Warnica W; Chin C; Théroux P
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S15-20. PubMed ID: 1725537
[TBL] [Abstract][Full Text] [Related]
28. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS).
Andrews TC; Fenton T; Toyosaki N; Glasser SP; Young PM; MacCallum G; Gibson RS; Shook TL; Stone PH
Circulation; 1993 Jul; 88(1):92-100. PubMed ID: 8319361
[TBL] [Abstract][Full Text] [Related]
29. Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol.
Luurila OJ; Gröhn P; Heikkilä J; Hämäläinen L; Härkönen R; Idänpään-Heikkilä U; Kohvakka A; Rytkönen U; Setälä M; Sundberg S
Am J Cardiol; 1987 Oct; 60(10):832-5. PubMed ID: 3310576
[TBL] [Abstract][Full Text] [Related]
30. [Effects of atenolol and diltiazem-SR on quality of life in the hypertensive patients].
Yao XY; Fan WH; Chen JZ; Zhu JH; Chen BX; Liu XJ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 32(3):231-4. PubMed ID: 12881870
[TBL] [Abstract][Full Text] [Related]
31. Diltiazem: effects on exercise performance in patients with coronary artery disease.
Starling MR; Crawford MH; O'Rourke RA
Int J Cardiol; 1982; 1(3-4):229-37. PubMed ID: 6284661
[TBL] [Abstract][Full Text] [Related]
32. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
[TBL] [Abstract][Full Text] [Related]
33. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.
Dargie HJ; Ford I; Fox KM
Eur Heart J; 1996 Jan; 17(1):104-12. PubMed ID: 8682116
[TBL] [Abstract][Full Text] [Related]
34. Open comparative study to assess the efficacy and safety of two calcium antagonists: amlodipine and diltiazem in the treatment of symptomatic myocardial ischemia.
Canale C; Terrachini V; Masperone MA; Caponnetto S
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S57-60. PubMed ID: 16296712
[TBL] [Abstract][Full Text] [Related]
35. Effects of diltiazem alone or with isosorbide dinitrate or with atenolol both acutely and chronically for stable angina pectoris.
el-Tamimi H; Davies GJ; Kaski JC; Vejar M; Galassi AR; Maseri A
Am J Cardiol; 1989 Oct; 64(12):717-24. PubMed ID: 2801521
[TBL] [Abstract][Full Text] [Related]
36. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
Davies RF; Goldberg AD; Forman S; Pepine CJ; Knatterud GL; Geller N; Sopko G; Pratt C; Deanfield J; Conti CR
Circulation; 1997 Apr; 95(8):2037-43. PubMed ID: 9133513
[TBL] [Abstract][Full Text] [Related]
37. Effect of diltiazem on sympathetic hyperactivity in patients with vasospastic angina as assessed by spectral analysis of arterial pressure and heart rate variability.
Yamasaki F; Sato T; Sugimoto K; Takata J; Chikamori T; Sasaki M; Doi Y
Am J Cardiol; 1998 Jan; 81(2):137-40. PubMed ID: 9591894
[TBL] [Abstract][Full Text] [Related]
38. Effects of atenolol vs diltiazem on the haemodynamic effects of an inhaled beta 2-adrenoceptor agonist.
Chapman KR; Galko BM; Smith DL; Leenen FH
Br J Clin Pharmacol; 1989 Feb; 27(2):268-71. PubMed ID: 2713221
[TBL] [Abstract][Full Text] [Related]
39. [Clinical and hemodynamic effects of diltiazem in patients with arterial hypertension associated with ischemic heart disease].
Bychko MV
Lik Sprava; 2007; (1-2):50-5. PubMed ID: 17682517
[TBL] [Abstract][Full Text] [Related]
40. The evidence regarding the drugs used for ventricular rate control.
Segal JB; McNamara RL; Miller MR; Kim N; Goodman SN; Powe NR; Robinson K; Yu D; Bass EB
J Fam Pract; 2000 Jan; 49(1):47-59. PubMed ID: 10678340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
